Annual CFO
-$22.08 M
-$28.65 M-436.17%
31 December 2023
Summary:
Co-Diagnostics annual cash flow from operations is currently -$22.08 million, with the most recent change of -$28.65 million (-436.17%) on 31 December 2023. During the last 3 years, it has fallen by -$50.25 million (-178.40%). CODX annual CFO is now -153.75% below its all-time high of $41.08 million, reached on 31 December 2021.CODX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.23 M
-$2.03 M-38.92%
30 September 2024
Summary:
Co-Diagnostics quarterly cash flow from operations is currently -$7.23 million, with the most recent change of -$2.03 million (-38.92%) on 30 September 2024. Over the past year, it has dropped by -$1.46 million (-25.40%). CODX quarterly CFO is now -136.22% below its all-time high of $19.96 million, reached on 31 December 2020.CODX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$25.70 M
-$1.46 M-6.04%
30 September 2024
Summary:
Co-Diagnostics TTM cash flow from operations is currently -$25.70 million, with the most recent change of -$1.46 million (-6.04%) on 30 September 2024. Over the past year, it has dropped by -$4.39 million (-20.60%). CODX TTM CFO is now -145.77% below its all-time high of $56.16 million, reached on 30 September 2021.CODX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -436.2% | -25.4% | -20.6% |
| 3 y3 years | -178.4% | -162.8% | -145.8% |
| 5 y5 years | -441.2% | -494.9% | -427.4% |
CODX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -153.8% | at low | -162.8% | +14.8% | -145.8% | at low |
| 5 y | 5 years | -153.8% | at low | -136.2% | +14.8% | -145.8% | at low |
| alltime | all time | -153.8% | at low | -136.2% | +14.8% | -145.8% | at low |
Co-Diagnostics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.23 M(+38.9%) | -$25.70 M(+6.0%) |
| June 2024 | - | -$5.20 M(-38.7%) | -$24.24 M(-1.7%) |
| Mar 2024 | - | -$8.49 M(+77.7%) | -$24.65 M(+11.7%) |
| Dec 2023 | -$22.08 M(-436.2%) | -$4.78 M(-17.1%) | -$22.08 M(+3.6%) |
| Sept 2023 | - | -$5.77 M(+2.6%) | -$21.31 M(+47.7%) |
| June 2023 | - | -$5.62 M(-5.0%) | -$14.43 M(+101.7%) |
| Mar 2023 | - | -$5.92 M(+47.6%) | -$7.15 M(-208.9%) |
| Dec 2022 | $6.57 M(-84.0%) | -$4.01 M(-458.6%) | $6.57 M(-57.5%) |
| Sept 2022 | - | $1.12 M(-32.4%) | $15.46 M(-40.2%) |
| June 2022 | - | $1.65 M(-78.8%) | $25.85 M(-29.4%) |
| Mar 2022 | - | $7.81 M(+60.0%) | $36.62 M(-10.9%) |
| Dec 2021 | $41.08 M(+45.9%) | $4.88 M(-57.6%) | $41.08 M(-26.9%) |
| Sept 2021 | - | $11.51 M(-7.4%) | $56.16 M(+5.5%) |
| June 2021 | - | $12.42 M(+1.3%) | $53.21 M(+27.4%) |
| Mar 2021 | - | $12.27 M(-38.5%) | $41.77 M(+48.3%) |
| Dec 2020 | $28.17 M | $19.96 M(+133.3%) | $28.17 M(+327.1%) |
| Sept 2020 | - | $8.56 M(+766.8%) | $6.60 M(-307.7%) |
| June 2020 | - | $987.10 K(-173.9%) | -$3.18 M(-42.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$1.34 M(-17.2%) | -$5.49 M(-0.6%) |
| Dec 2019 | -$5.53 M(+35.4%) | -$1.61 M(+32.7%) | -$5.53 M(+13.4%) |
| Sept 2019 | - | -$1.22 M(-8.5%) | -$4.87 M(+0.7%) |
| June 2019 | - | -$1.33 M(-2.9%) | -$4.84 M(+8.1%) |
| Mar 2019 | - | -$1.37 M(+42.5%) | -$4.48 M(+9.8%) |
| Dec 2018 | -$4.08 M(+27.0%) | -$960.60 K(-18.8%) | -$4.08 M(-0.8%) |
| Sept 2018 | - | -$1.18 M(+22.2%) | -$4.11 M(-8.2%) |
| June 2018 | - | -$968.00 K(-0.1%) | -$4.48 M(+19.2%) |
| Mar 2018 | - | -$968.50 K(-2.4%) | -$3.76 M(+17.1%) |
| Dec 2017 | -$3.21 M(+144.7%) | -$992.40 K(-36.0%) | -$3.21 M(+15.7%) |
| Sept 2017 | - | -$1.55 M(+525.8%) | -$2.77 M(+82.4%) |
| June 2017 | - | -$247.90 K(-40.9%) | -$1.52 M(+2.8%) |
| Mar 2017 | - | -$419.70 K(-24.5%) | -$1.48 M(+12.8%) |
| Dec 2016 | -$1.31 M(-14.3%) | -$555.90 K(+86.5%) | -$1.31 M(+73.5%) |
| Sept 2016 | - | -$298.10 K(+44.6%) | -$756.40 K(+65.0%) |
| June 2016 | - | -$206.10 K(-18.3%) | -$458.30 K(+81.7%) |
| Mar 2016 | - | -$252.20 K | -$252.20 K |
| Dec 2015 | -$1.53 M | - | - |
FAQ
- What is Co-Diagnostics annual cash flow from operations?
- What is the all time high annual CFO for Co-Diagnostics?
- What is Co-Diagnostics annual CFO year-on-year change?
- What is Co-Diagnostics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Co-Diagnostics?
- What is Co-Diagnostics quarterly CFO year-on-year change?
- What is Co-Diagnostics TTM cash flow from operations?
- What is the all time high TTM CFO for Co-Diagnostics?
- What is Co-Diagnostics TTM CFO year-on-year change?
What is Co-Diagnostics annual cash flow from operations?
The current annual CFO of CODX is -$22.08 M
What is the all time high annual CFO for Co-Diagnostics?
Co-Diagnostics all-time high annual cash flow from operations is $41.08 M
What is Co-Diagnostics annual CFO year-on-year change?
Over the past year, CODX annual cash flow from operations has changed by -$28.65 M (-436.17%)
What is Co-Diagnostics quarterly cash flow from operations?
The current quarterly CFO of CODX is -$7.23 M
What is the all time high quarterly CFO for Co-Diagnostics?
Co-Diagnostics all-time high quarterly cash flow from operations is $19.96 M
What is Co-Diagnostics quarterly CFO year-on-year change?
Over the past year, CODX quarterly cash flow from operations has changed by -$1.46 M (-25.40%)
What is Co-Diagnostics TTM cash flow from operations?
The current TTM CFO of CODX is -$25.70 M
What is the all time high TTM CFO for Co-Diagnostics?
Co-Diagnostics all-time high TTM cash flow from operations is $56.16 M
What is Co-Diagnostics TTM CFO year-on-year change?
Over the past year, CODX TTM cash flow from operations has changed by -$4.39 M (-20.60%)